Join us on Monday, June 8 at 10:00 am ET for a patient-centered discussion on idiopathic intracranial hypertension (IIH) and the recently FDA-approved River Stent™. Chaniya will share her personal experience living with IIH, including her journey before and after the River Stent™ placement. Moderated by Dr. Pierre Gobin, this session will offer valuable insight into the patient perspective and the real-world impact of this new treatment option for IIH.
Dr. Y Pierre Gobin
Director of Interventional Neuroradiology, New York-Presbyterian Hospital/Weill Cornell Medical Center
Idiopathic Intracranial Hypertension (IIH) is an underdiagnosed and undertreated disorder of elevated pressure within the brain without an identifiable cause. The IIH Practioner Series is designed for neurologists, neurosurgeons, neuro-interventionalists, endovascular surgeons, interventionist radiologists, neuroradiologists, ophthalmologists, optometrists, and ENT specialists.
Sponsored by
Novel neurovascular therapies for idiopathic intracranial hypertension (IIH)
